Status:
RECRUITING
An In-situ Detection for MicroRNA
Lead Sponsor:
Tongji Hospital
Conditions:
Breast Cancer
Eligibility:
FEMALE
18-75 years
Brief Summary
We designed a new in-site detection method for MicroRNA in the serum of patients with breast cancer.
Eligibility Criteria
Inclusion
- Healthy without serious diseases
- \-
Exclusion
- situations that may affect the results
Key Trial Info
Start Date :
July 20 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06529614
Start Date
July 20 2024
End Date
November 1 2025
Last Update
October 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tongji Hospital
Wuhan, Hubei, China, 430030